Understanding MDS risk classification enhances patient care, focusing on tailored therapies and improving quality of life ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...

Poster outlines clinical benefit with acceptable safety profile across 9 tested dosing regimensAccelerated step-up dosing and higher dosing ...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, today featured ...

The MarketWatch News Department was not involved in the creation of this content. SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing ...

SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders ...

Complications from myelodysplastic syndromes (MDS), like anemia or fatigue, can occur because the bone marrow isn’t making enough healthy or functional blood cells. Myelodysplastic syndromes (MDS) are ...

Andrew M. Brunner, MD, discusses the mechanism of action of telomerase inhibitors as treatment for anemia related to myelodysplastic syndrome. Andrew M. Brunner, MD, assistant professor of medicine at ...

German researchers found that 5G radiation, even at ten times the legal exposure limit, caused no harmful changes to human skin cells. The study was carefully controlled for temperature, which matters ...

Researchers have discovered a secret super power that cancer cells exhibit while squeezing themselves through our bodies. The finding now gives scientists the chance to discover the kryptonite that ...